Biosimilar White Papers

1. Leading The Edge Of Innovation Into Cell Culture Media Quality 12/16/2020

   In this white paper, we highlight the breadth of programs implemented across our organization to safeguard the quality of the cell culture media that are used in our customer processes.

2. Placing Drug Strategies On A Solid Foundation For Success 4/21/2022

   Explore how certain drivers are impacting traditional drug development strategies and relationships with outsourced drug development and manufacturing partners.

3. End Of End Point Assays: SPR Analytics In Vaccine Design, Development 2/18/2021

   Discover how SPR can be used to accelerate vaccine discovery and development by helping overcome analytical challenges that have plagued the industry for decades.

4. Explore Protein Function Using Surface Plasmon Resonance (SPR) 5/20/2021

   We’ve collected a few examples of how an academic research group used Biacore™ X100 SPR system in their research to investigate protein-RNA, protein-protein interactions, and how researchers have used SPR to measure antibody specificity. Download the white paper A year of interaction with Biacore™ X100.

5. Secure The Cell Therapy Supply Chain From Bench To Bedside 10/4/2021

   While current approaches can manage the existing volume of cell therapy shipments, scaling these treatments up and out will increase pressure on cryogenic logistics networks. 

6. Outstanding Sensitivity For Confident SPR Interaction Analysis 7/20/2022

   Explore how surface plasmon resonance (SPR)-based analyses with a high sensitivity instrument can provide greater data precision and better confidence in your results interpretation.

7. Regulatory Considerations For Alternative Microbial Methods 2/28/2022

   This paper discusses the regulatory expectations for incorporation of alternative methods with a focus on comparability and strategies for easier substitution of current methods.

8. Guidelines For A High Cell Density Cryopreservation Process 8/11/2021

   A discussion on the integration of high cell density cryopreservation in the seed train andkey considerations for developing a cryopreservation process including choice of cryoprotectant and freezing techniques.

9. Taking Charge Of Your Stability Program 10/5/2022

   Learn how consolidating stability testing with a single partner offers improved efficiency, reduced risk, and more.

10. De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector 6/2/2022

    Discover how a biopharmaceutical company can de-risk the launch process by choosing a suitable autoinjector technology and partner.